Cellares
ID: 6344354Cellares is a biotechnology and cell therapy company founded in 2019 by Fabian Gerlinghaus, Alex Pesch, and Omar Kurdi.
2
Funding Rounds
$339.0m
Money raised
Recent Funding Rounds
Overview
Cellares is a biotechnology and cell therapy company founded in 2019 by Fabian Gerlinghaus, Alex Pesch, and Omar Kurdi.
- Website:
- Business model: B2B
- Social accounts: linkedin
Unlock Complete Company Intelligence
Access comprehensive data and insights available only to Seedtable members
Financial Details
- • Complete funding history and valuations
- • Revenue estimates and financial metrics
- • Investment round details and terms
People & Contacts
- • Complete leadership team profiles
- • Contact information and email addresses
- • Board members and advisors
Market Intelligence
- • Competitive landscape analysis
- • Market position and growth metrics
- • Industry benchmarking data
Premium Tools
- • Export data and generate reports
- • Save companies to custom watchlists
- • API access for data integration
Join 10,000+ Professionals
Trusted by investors, founders, and analysts worldwide
Access detailed insights on 71,000+ companies worldwide
| Name | Phone | Social networks | |
|---|---|---|---|
| Fa**** Ge********* |
|
- | linkedin twitter facebook |
| Al** Pe*** |
|
- | |
| Om** Ku*** | - | - |
| Name | Phone | Social networks | |
|---|---|---|---|
| Vi**** To** | - | - | linkedin twitter instagram |
| Name | Phone | Social networks | |
|---|---|---|---|
| Fa**** Ge********* |
|
- | linkedin twitter facebook |
| Om** Ku*** | - | - |
Funding
Funding series
Funding Series Analysis
The company Cellares has raised a total of $339m in funding over 2 rounds.
Key Insights:
- Cellares January 2026 Series D Funding Round: $257m
- Cellares Series B round, May 2021: $82m
Industries
Cellares is active in the following industries: